Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 55

Related Articles by Review for PubMed (Select 16115821)

1.

Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders.

Djouadi F, Aubey F, Schlemmer D, Ruiter JP, Wanders RJ, Strauss AW, Bastin J.

Hum Mol Genet. 2005 Sep 15;14(18):2695-703. Epub 2005 Aug 22.

2.

PPARs as therapeutic targets for correction of inborn mitochondrial fatty acid oxidation disorders.

Djouadi F, Bastin J.

J Inherit Metab Dis. 2008 Apr;31(2):217-25. doi: 10.1007/s10545-008-0844-7. Epub 2008 Apr 4. Review.

PMID:
18392740
3.

Mutation analysis in mitochondrial fatty acid oxidation defects: Exemplified by acyl-CoA dehydrogenase deficiencies, with special focus on genotype-phenotype relationship.

Gregersen N, Andresen BS, Corydon MJ, Corydon TJ, Olsen RK, Bolund L, Bross P.

Hum Mutat. 2001 Sep;18(3):169-89. Review.

PMID:
11524729
4.

Genetic and cellular modifiers of oxidative stress: what can we learn from fatty acid oxidation defects?

Olsen RK, Cornelius N, Gregersen N.

Mol Genet Metab. 2013;110 Suppl:S31-9. doi: 10.1016/j.ymgme.2013.10.007. Epub 2013 Oct 12. Review.

PMID:
24206932
5.

Disorders of mitochondrial fatty acyl-CoA beta-oxidation.

Wanders RJ, Vreken P, den Boer ME, Wijburg FA, van Gennip AH, IJlst L.

J Inherit Metab Dis. 1999 Jun;22(4):442-87. Review.

PMID:
10407780
6.

Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening.

Spiekerkoetter U.

J Inherit Metab Dis. 2010 Oct;33(5):527-32. doi: 10.1007/s10545-010-9090-x. Epub 2010 May 7. Review.

PMID:
20449660
7.

Mouse models for disorders of mitochondrial fatty acid beta-oxidation.

Schuler AM, Wood PA.

ILAR J. 2002;43(2):57-65. Review.

9.

Regulation of mitochondrial fatty acid β-oxidation in human: what can we learn from inborn fatty acid β-oxidation deficiencies?

Bastin J.

Biochimie. 2014 Jan;96:113-20. doi: 10.1016/j.biochi.2013.05.012. Epub 2013 Jun 10. Review.

PMID:
23764392
10.

Intramitochondrial fatty acid metabolism: riboflavin deficiency and energy production.

Parsons HG, Dias VC.

Biochem Cell Biol. 1991 Jul;69(7):490-7. Review.

PMID:
1793560
11.

Clinical and biochemical monitoring of patients with fatty acid oxidation disorders.

Lund AM, Skovby F, Vestergaard H, Christensen M, Christensen E.

J Inherit Metab Dis. 2010 Oct;33(5):495-500. doi: 10.1007/s10545-009-9000-2. Epub 2010 Jan 12. Review.

PMID:
20066495
12.
13.

Disorders of mitochondrial long-chain fatty acid oxidation.

Pollitt RJ.

J Inherit Metab Dis. 1995;18(4):473-90. Review.

PMID:
7494405
14.

Carnitine deficiency disorders in children.

Stanley CA.

Ann N Y Acad Sci. 2004 Nov;1033:42-51. Review.

PMID:
15591002
15.

State of the art in muscle lipid diseases.

Liang WC, Nishino I.

Acta Myol. 2010 Oct;29(2):351-6. Review.

16.

Metabolic myopathies.

Tein I.

Semin Pediatr Neurol. 1996 Jun;3(2):59-98. Review.

PMID:
8795843
17.

Mitochondrial fatty acid oxidation disorders: pathophysiological studies in mouse models.

Spiekerkoetter U, Wood PA.

J Inherit Metab Dis. 2010 Oct;33(5):539-46. doi: 10.1007/s10545-010-9121-7. Epub 2010 Jun 8. Review.

18.

Mitochondrial fatty acid oxidation disorders and cyclic vomiting syndrome.

Rinaldo P.

Dig Dis Sci. 1999 Aug;44(8 Suppl):97S-102S. Review.

PMID:
10490047
19.

Clinical and biochemical features of fatty acid oxidation disorders.

Rinaldo P, Raymond K, al-Odaib A, Bennett MJ.

Curr Opin Pediatr. 1998 Dec;10(6):615-21. Review.

PMID:
9848022
20.

[Very-long-chain acyl-CoA dehydrogenase deficiency presenting with recurrent rhabdomyolysis in an adult].

Hamano H, Shinohara Y, Takizawa S, Tokuoka K, Kazahari S, Mandokoro H, Sato A.

Rinsho Shinkeigaku. 2003 May;43(5):253-7. Review. Japanese.

PMID:
12931630
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk